|
Archemix Rings Up $35M in Deals with Merck
Serono, Takeda
(6/12) Laurie Sullivan, PharmaWeek
Settling
Rosiglitazone's Safety Score
(6/7) Laurie Sullivan, PharmaWeek
Massive
Genetic Study Finds Links for Major Common Diseases
(6/7) The Guardian, Wellcome Trust
Amgen
Acquiring Alantos for $300M
(6/6) Amgen
Amgen
Acquiring Ilypsa for $420M
(6/4) Amgen
DxS
Launches K-RAS Mutation Detection Kit
(6/4) DxS
Bayer/Onyx's
Nexavar Extends Survival in Phase III Liver Cancer Trial
(6/4) Onyx Pharmaceuticals
QIAGEN
Buying Digene for $1.6B
(6/3) QIAGEN
FDA
Approves TORISEL, a Targeted First-in-Class mTOR Inhibitor
for the Treatment of Advanced Kidney Cancer
(5/30) Wyeth
Genzyme
Acquiring Bioenvision for $345M
(5/29) Company press release
Study
Links Rosiglitazone and Cardiovascular Risk
(5/21) The New England Journal of Medicine
Geron
Reports on Insulin-Producing Embryonic Stem Cells
(5/17) Reuters
Biosite
Says Inverness' Offer Is Superior; Beckman Coulter Will
Not Budge
(5/14) Press releases
Mylan
Buying Merck KGaA's Generics Unit for $6.6B
(5/13) Reuters
Gene
Logic Working on Alternative Development Paths for Abbott
Phase I Compounds
(5/10) Gene Logic
Senate
Votes to Step up Drug Monitoring
(5/10) AP/Chicago Tribune
Bristol-Myers
Squibb and Isis Ink $190M Plus CV Deal
(5/9) Malorye Allison, PharmaWeek
Mass.
Governor Deval Patrick Unveils $1B Life Science Initiative
(5/8) Press release
Reveo
Throws Hat Into $10M X PRIZE Genome-Sequencing Competition
(5/3) Business Wire
Bristol-Myers'
Banner Day: Company Strikes $1B Deal with Pfizer, Elects
James M. Cornelius as CEO, Raises 2007 Earnings Guidance
(4/26) Bristol-Myers Squibb
Novartis
Licensing Cytos' Anti-Smoking Vaccine for $500M
(4/25) Cytos Biotechnology
AstraZeneca
Acquiring MedImmune for $15.2B
(4/23) Laurie Sullivan, PharmaWeek
Antisoma Could Fetch $890M in Deal with Novartis
(4/19) Antisoma
Senate
Vote Blocks Medicare from Negotiating Lower Drug Prices
(4/18) The New York Times
FDA
Approves First Bird Flu Vaccine
(4/17) Laurie Sullivan, PharmaWeek
Ernst
& Young: 2006 Reveals Biotech's Shifting Paradigm
(4/16) Ernst & Young QIAGEN
Offering $34M for eGene
(4/12) QIAGEN
FDA
Advisory Panel Votes Against Approval for Merck's Arcoxia
(4/12) Laurie Sullivan, PharmaWeek
Transgene
Strikes $293M HPV Vaccine Deal with Roche
(4/11) Transgene
Agilent
Acquiring Stratagene for About $246.2M
(4/9) Malorye Allison, PharmaWeek
Generic
Biotech Drugs Getting Bipartisan Support in Congress
(4/7) The New York Times
Roche
Acquires BioVeris for $600M
(4/4) Roche
Thomson/WARF
Stem Cell Patents Rejected
(4/3) The New York Times
PerkinElmer
Acquires Improvision, a Cellular Imaging Company
(4/3) Company press release
Roche
Pays $56.5M for Therapeutic Human Polyclonals, Inc.
(4/2) Roche
Ads
Return for Pfizer's Celebrex
(4/2) Forbes.com
LG
Life Sciences, Takeda Strike $100M Pact
(3/30) LG Life Sciences
Astellas
Licenses Regeneron's Antibody Technology for Up To $120M
(3/30) Astellas Pharma
Roche
Buys 454 From CuraGen
(3/29) Company press release
Pergolide
Products for Parkinson's Being Withdrawn
(3/29) FDA press release
Sanofi-Aventis
is Split Over Possible Acquisition of Bristol-Myers
(3/27) Reuters
Merck
and Schering-Plough Developing Cholesterol-Lowering
Combination
(3/27) Malorye Allison, PharmaWeek
Data
from Pfizer Pill Study Keep CETP Inhibitors in Play
(3/26) Malorye Allison, PharmaWeek
Eli
Lilly Expanding Its Singapore R&D Activities
(3/26) Company press release
Beckman
Coulter Acquiring Proteomics Diagnostics Firm Biosite
(3/25) Company press release
FDA's
Final PDUFA Recommendations Call for $87.4M Increase in
Annual User Fees
(3/23) FDA News
Angel
Investment Up 10.8% in 2006, Rivaling Venture Capital
Levels
(3/20) The Boston Globe GSK
Invests $13M to Open New Lab in Singapore
(3/20) AP/Forbes.com Boehringer
Ingelheim Teams With Evotec AG and Vienna's IMP on
Alzheimer's Treatments
(3/19) PR Newswire Micromet,
TRACON in $100M Pact to Develop and Commercialize Antibody
for Cancer Treatment
(3/16) TRACON Pharmaceuticals From
Wall Street, A Warning About Cancer-Drug Prices
(3/15) The Wall Street Journal
Bristol-Myers
Expands R&D in India
(3/14) Bristol-Myers Squibb
FDA
Approves Tykerb for Treatment of Advanced Breast Cancer
(3/13) FDA News
Takeda
Pharmaceutical Company To Acquire Paradigm Therapeutics
(3/12) Takeda Pharmaceutical Company Limited
Easing
the Early-Stage Company Funding Crisis
(3/12) Malorye A. Branca, PharmaWeek
Jazz
Pharmaceuticals Files $172.5M IPO
Reuters (3/9)
FDA
Issues Safety Update about Aranesp, Epogen and Procrit
(3/9) FDA News
Galapagos
to Supply Small-Molecule Compounds to Johnson &
Johnson
(3/8) Galapagos NV
Stem
Cell Experts Examine Growing Field's Prospects
(3/6) Malorye A. Branca
BioCryst,
Shionogi in Flu Drug Agreement Worth Up To $130M
(3/5) PR Newswire
Report
Blasts FDA's System to Track Drugs
(3/3) The Wall Street Journal Argenta
Discovery, Genentech Expand Drug Discovery Pact
(3/1) Argenta Discovery Pfizer's
Novel Anti-HIV Drug May be Next Personalized Medicine
Approved
(2/28) Malorye A. Branca, PharmaWeek
EvoGenix,
Vegenics Strike Antibody Collaboration
(2/27) EvoGenix
Liver
Toxicity Study Begins with Collective Support
(2/23) Allison Proffitt,
PharmaWeek
Pfizer
CEO Kindler Joins BIO Board
(2/22) Malorye A. Branca, PharmaWeek
Analysis
of Phase III Data Shows Avastin Plus Chemotherapy Prolongs
Progression-Free Survival in Lung Cancer Patients
(2/21) Genentech
BIO
CEO Panel Forecasts Impact of New Congress
(2/20) Malorye A. Branca, PharmaWeek Shire
Pays $2.6B for New River Pharmaceuticals, Gains ADHD Drug
(2/20) Reuters
Legislation Would Allow FDA
to Approve Biogenerics
(2/15)
EmpireStateNews.net
Amgen CEO Gives Update, Discusses Patent Dispute with Roche
(2/8) Pharma DD
Applied Biosystems Updates Investors at Merrill Lynch Conference
(2/6) Pharma DD
Elbion, Wyeth Pharmaceuticals Strike $110M Deal for CNS Disorders
(2/5) PR Newswire
Regeneron, AstraZeneca Sign $120M mAB Agreement
(2/5) Regeneron Pharmaceuticals
Mitsubishi Pharma and Tanabe in $4.3B Merger Deal
(2/2) Reuters
AstraZeneca in Deals Worth Up To $800M
(1/31) Company press releases
Thailand Will Suspend Companies' Drug Patents
(1/30) The Wall Street Journal
GSK
Accused of Hiding Link Between Antidepressant and Suicide in Teens
(1/29) Reuters
|
